preprint · Research Square

Mortality Benefits of DPP-4 Inhibitors Compared to Other Oral Hypoglycemic Agents or Placebo in Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials

Issack Alio Issak
Joel Mumo Musyoki
Annette Njeri Maina
Faith Kendi Mwenda
Lilian Mumbi Kariuki
Naomi Bett Chepkirui
Calvin David Wanyama
Jimmy Njoroge

2026Open accessKenya Methodist University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Diabetes Treatment and Management
Bariatric Surgery and Outcomes
Peptidase Inhibition and Analysis

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.21203/rs.3.rs-9523684/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.